Cargando…

Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data

OBJECTIVE: We report analyses of a pooled database by the Multiple Sclerosis Outcome Assessments Consortium to evaluate 4 proposed components of a multidimensional test battery. METHODS: Standardized data on 12,776 participants, comprising demographics, multiple sclerosis disease characteristics, Ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldman, Myla D., LaRocca, Nicholas G., Rudick, Richard A., Hudson, Lynn D., Chin, Peter S., Francis, Gordon S., Jacobs, Adam, Kapoor, Raj, Matthews, Paul M., Mowry, Ellen M., Balcer, Laura J., Panzara, Michael, Phillips, Glenn, Uitdehaag, Bernard M.J., Cohen, Jeffrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885577/ https://www.ncbi.nlm.nih.gov/pubmed/31641014 http://dx.doi.org/10.1212/WNL.0000000000008519

Ejemplares similares

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
por: LaRocca, Nicholas G, et al.
Publicado: (2017)

Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
por: Balcer, Laura J, et al.
Publicado: (2017)

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2017)

Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
por: Motl, Robert W, et al.
Publicado: (2017)

The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
por: Feys, Peter, et al.
Publicado: (2017)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis
por: Strober, Lauren, et al.
Publicado: (2018)

Retrospective cohort study of the relationship between systolic blood pressure variability and multiple sclerosis disability
por: Goldman, Myla D, et al.
Publicado: (2020)

Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment
por: Cohen, Jeffrey A, et al.
Publicado: (2019)

Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
por: Uitdehaag, Bernard M. J.
Publicado: (2018)

Retinal measurements predict 10‐year disability in multiple sclerosis
por: Rothman, Alissa, et al.
Publicado: (2019)

Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set
por: Koch, Marcus W., et al.
Publicado: (2017)

Clinical pharmacology of alemtuzumab, an anti‐CD52 immunomodulator, in multiple sclerosis
por: Li, Z., et al.
Publicado: (2018)

Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2020)

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients
por: Giovannoni, Gavin, et al.
Publicado: (2016)

Smoking Cessation Considerations for People with Multiple Sclerosis
por: Brooker, Christa, et al.
Publicado: (2020)

Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
por: Dekker, Iris, et al.
Publicado: (2019)

Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosis
por: Keller, Jennifer L., et al.
Publicado: (2022)

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2017)

Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life
por: Chahin, Salim, et al.
Publicado: (2015)

Early Aggressive Treatment Approaches for Multiple Sclerosis
por: Simpson, Alexandra, et al.
Publicado: (2021)

Walking impairment in patients with multiple sclerosis: exercise training as a treatment option
por: Motl, Robert W, et al.
Publicado: (2010)

Gait Speed Trajectory During the Six-Minute Walk Test in Multiple Sclerosis: A Measure of Walking Endurance
por: Chen, Shanshan, et al.
Publicado: (2021)

Multiple Sclerosis Performance Test: Technical Development and Usability
por: Rhodes, Jane K., et al.
Publicado: (2019)

The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis
por: Brenton, J. Nicholas, et al.
Publicado: (2019)

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
por: Rudick, Richard A., et al.
Publicado: (2014)

Obesity's role in MS: An intervention target with possible interactions
por: Fitzgerald, Kathryn C., et al.
Publicado: (2020)

Guía clínica de enfermería : Terapia intravenosa /
por: LaRocca, Joanne C.
Publicado: (1994)

Tratamiento intravenoso
por: LaRocca, Joanne C.
Publicado: (1991)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities
por: Motl, Robert W, et al.
Publicado: (2017)

Anxiety is more important than depression in MS – Commentary
por: de Jong, Brigit A, et al.
Publicado: (2018)

Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients
por: Goldman, Myla D., et al.
Publicado: (2020)

Commentary: Type I Interferon Response Is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury
por: McEntee, Cali M., et al.
Publicado: (2022)

Translating Innovation in Diagnostics: Challenges and Opportunities
por: Brown, Matthew P., et al.
Publicado: (2009)

Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability
por: Brier, Matthew R., et al.
Publicado: (2021)

Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
por: McAllister, Peter, et al.
Publicado: (2022)

Psychosocial challenges of children with disabilities in Sekhukhune District, Limpopo province of South Africa: Towards a responsive integrated disability strategy
por: Makwela, Matthews M., et al.
Publicado: (2022)

Disability and COVID-19
por: Mörchen, Manfred, et al.
Publicado: (2020)

From sex-ed to fertility-ed: a more holistic approach to reproductive education
por: Rudick, Briana
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_580cjfqqngjf8nnq5rdv4ibnuc